Page last updated: 2024-08-24

thiazolyl blue and yttrium radioisotopes

thiazolyl blue has been researched along with yttrium radioisotopes in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huijgens, PC; Jonkhoff, AR; Martens, HJ; Ossenkoppele, GJ; Teule, GJ; van Dieren, EB; Versteegh, RT	1
Blumenthal, RD; Goldenberg, DM; Leone, E; Modrak, D; Rodriguez, M	1

Other Studies

2 other study(ies) available for thiazolyl blue and yttrium radioisotopes

Article	Year
Gallium-67 radiotoxicity in human U937 lymphoma cells. British journal of cancer, 1993, Volume: 67, Issue:4 Topics: Cell Division; Gallium Radioisotopes; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplastic Stem Cells; Radiotherapy Dosage; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Yttrium Radioisotopes	1993
An in vitro model to optimize dose scheduling of multimodal radioimmunotherapy and chemotherapy: effects of p53 expression. International journal of cancer, 2004, Jan-10, Volume: 108, Issue:2 Topics: Antineoplastic Agents; Carboplatin; Cell Division; Combined Modality Therapy; Dose-Response Relationship, Drug; Doxorubicin; Drug Antagonism; Drug Resistance, Neoplasm; Drug Synergism; Female; Genetic Therapy; Humans; In Vitro Techniques; Mutation; Ovarian Neoplasms; Paclitaxel; Radioimmunotherapy; Tetrazolium Salts; Thiazoles; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Yttrium Radioisotopes	2004

Article

Year

Gallium-67 radiotoxicity in human U937 lymphoma cells.

British journal of cancer, 1993, Volume: 67, Issue:4

Topics: Cell Division; Gallium Radioisotopes; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplastic Stem Cells; Radiotherapy Dosage; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Yttrium Radioisotopes

1993

An in vitro model to optimize dose scheduling of multimodal radioimmunotherapy and chemotherapy: effects of p53 expression.

International journal of cancer, 2004, Jan-10, Volume: 108, Issue:2

Topics: Antineoplastic Agents; Carboplatin; Cell Division; Combined Modality Therapy; Dose-Response Relationship, Drug; Doxorubicin; Drug Antagonism; Drug Resistance, Neoplasm; Drug Synergism; Female; Genetic Therapy; Humans; In Vitro Techniques; Mutation; Ovarian Neoplasms; Paclitaxel; Radioimmunotherapy; Tetrazolium Salts; Thiazoles; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Yttrium Radioisotopes

2004